Non-Hodgkin Lymphoma
University of Pisa, Department of Experimental Pathology details research in non-hodgkin lymphoma
Published in Drug Week, December 31st, 2010
2010 DEC 31 -- Researchers detail in 'Inclusion of rituximab in treatment protocols for non-Hodgkin's lymphomas and risk for progressive multifocal leukoencephalopathy,' new data in non-hodgkin lymphoma. "Rituximab is an anti-CD20 monoclonal antibody that promotes better treatment outcomes in patients with non-Hodgkin's lymphoma (NHL). Case series of progressive multifocal leukoencephalopathy (PML) in patients receiving rituximab within polychemotherapy regimens have led to the introduction of a black box warning, but no risk estimation has ever been provided," researchers in Pisa, Italy report.
"We performed a retrospective, monocentric cohort study on 976...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2010-12-31)
More Articles from Drug Week
- Metalloporphyrins
Wonkwang University, Research Center reports research in metalloporphyrins - Alzheimer Disease
Unraveling Alzheimer's: Simple small molecules could untangle complex disease - Proteomics
University of Wisconsin-Madison, Department of Nutritional Sciences details research in proteomics - Stem Cell Research
University of Wisconsin-Madison publishes research in stem cell research - Bioelectronics
University of Twente, Institute of Nanotechnology publishes research in bioelectronics - Schizophrenia
University of Pittsburgh reports research in schizophrenia - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
